市場調查報告書
商品編碼
1433342
全球過濾針市場 2023-2030Global Filter Needles Market 2023-2030 |
預計在預測期內(2023-2030年),全球過濾針市場將以7.4%的CAGR成長。老年人口增加、糖尿病盛行率增加、燒傷、道路事故和創傷事件以及手術過程等事故病例增加等關鍵因素是推動市場的主要因素。
全球過濾針市場根據類型和最終用戶進行區隔。根據類型,市場分為不銹鋼和玻璃。此外,根據最終用戶,市場分為醫院、診所和門診手術中心。在最終用戶中,由於門診手術的顯著轉變、特定手術的適當專業化、對微創手術的日益關注以及採用技術進步。
在原料中,玻璃區隔市場預計將在全球過濾針市場中佔據相當大的佔有率。區隔市場的成長歸因於玻璃針的幾個優點,例如適合高精度工作、低體積誤差和成本效率,預計將推動市場發展。玻璃針的這些優點使其適合在類似的醫療技術領域使用。根據美國國立衛生研究院的研究,發表的文章《單劑量安瓿中摻假的玻璃顆粒:患者安全問題》使用過濾針頭並傾斜安瓿可以幫助減少進入注射器溶液中的玻璃顆粒數量。
全球過濾針市場根據地理位置進一步區隔,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於新興經濟體的治療率上升、可支配收入增加和醫療基礎設施改善正在推動亞太地區的過濾針市場,預計亞太地區將在全球市場中佔據顯著佔有率。
在所有地區中,北美地區預計在預測期內將以相當大的CAGR成長。由於手術數量增加、對創新過濾針的需求增加以及醫療保健支出增加等因素預計將推動預測期內的市場成長,北美市場正在成長。根據經濟合作暨發展組織(OECD)的數據,2021年,美國醫療保健支出佔國內生產毛額(GDP)的17.8%,幾乎是經合組織國家平均水準的兩倍。此外,心血管和神經系統疾病等慢性疾病的盛行率正在快速成長,加速了北美手術持針器市場的發展。美國代謝與減肥外科學會預計,2021 年,2 型糖尿病將成為最常見的糖尿病形式。美國有 3,260 萬人患有第 2 型糖尿病。此外,這種疾病導致許多嚴重的健康問題,包括心臟病、中風、高血壓、腎衰竭、失明、皮膚傷口、神經損傷(神經病變)、勃起功能障礙和認知能力下降等。此類疾病需要手術,預計將推動過濾針市場的需求。
服務過濾針市場的主要公司包括 ICU Medical Inc.、MYCO Medical Supplies, Inc.、Novo Nordisk Inc.、Sentra Medical、Sol-Millennium Medical Group、Stryker Corp.、Terumo Corp.、Thermo Fisher Scientific Inc. 和其他。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2023 年 4 月,CarrTech Corp. 開發了 FROG (R) 過濾針,這是一項改變產業的創新。 FROG (R) 是他們的旗艦產品,代表「過濾去除玻璃」。這種革命性的設備是第一個也是唯一一個將過濾器和皮下注射針組合在一起的一體式包裝。蘇數十年的專業經驗啟發了她,她看到了打開玻璃安瓿並從中提取藥物的危險。
Global Filter Needles Market Size, Share & Trends Analysis Report by Raw Material (Stainless-Steel and Glass), by End-User (Hospital, Clinics, and Ambulatory Surgery Centers), Forecast Period (2023-2030)
The global filter needles market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). Pivotal factors such as the increasing geriatric population, increasing prevalence of diabetes, the increasing cases of accidents such as burns, road accidents and trauma incidences and surgical processes are some of the major factors driving the market.
The global filter needles market is segmented based on the type, and end-user. Based on the type, the market is sub-segmented into stainless steel and glass. Further, based on end user, the market is sub-segmented into hospital, clinics, and ambulatory surgery centers. Among the end user, the ambulatory surgical centers sub-segment is anticipated to hold a considerable share of the market, owing to the significant shift toward outpatient procedures, proper specialization in specific procedures, the rising focus on minimally invasive procedures, and the adoption of technological advancements.
Among the raw material, the glass sub-segment is expected to hold a considerable share of the global filter needles market. Segmental growth is attributed to several advantages of glass needles, such as suitability for high precision work, low volume error, and cost efficiency, are projected to drive the market. These advantages of glass needles make them appropriate for use in fields comparable medical technology. According to the National Institutes of Health study, article published Glass particulate adulterated in single dose ampoules: A patient safety concern, using filtered needles and leaning the ampoules can help reduce the number of glass particulates that pass into the solutions being drawn into the syringes.
The global filter needles market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising treatment rates, the rising disposable income and improving healthcare infrastructure in emerging economies are driving the filter needles market in the Asia-Pacific.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising number of surgeries, increasing demand for innovative filter needles, and rising healthcare expenditure are projected to drive market growth over the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Further, rising prevalence of chronic diseases, such as cardiovascular and neurological disorders is growing at a rapid pace thus accelerating the surgical needle holder market in North America. American Society for Metabolic and Bariatric Surgery, in 2021, type 2 diabetes, the most common form of diabetes. There are 32.6 million people in the US living with type 2 diabetes. Moreover, this disease led to many serious health problems including heart disease, stroke, high blood pressure, kidney failure, blindness, skin wounds, nerve damage (neuropathy), erectile dysfunction, and cognitive decline among many others. Such diseases required to the surgery which anticipate propelling the demand for filter needles market.
The major companies serving the filter needles market include ICU Medical Inc., MYCO Medical Supplies, Inc., Novo Nordisk Inc., Sentra Medical, Sol-Millennium Medical Group, Stryker Corp., Terumo Corp., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2023, CarrTech Corp. developed FROG® filter needle, an industry-altering innovation. FROG®, their flagship product, stands for "filter removal of glass." This revolutionary device is the first and only all-in-one package filter and hypodermic needle combined. Sue was inspired by decades of professional experience, seeing the dangers associated with opening and extracting medicines from glass ampoules.